Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery

The award supports eXoZymes’ efforts to make rare cannabinoid-like molecules for drug discovery and expand its proprietary portfolio, the company said.

Summary by The Norfolk Daily News
Total non-dilutive funding awarded to eXoZymes is now almost $20 million, validating the scalable nature of the

5 Articles

The Norfolk Daily NewsThe Norfolk Daily News
+3 Reposted by 3 other sources
Center

eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery

Total non-dilutive funding awarded to eXoZymes is now almost $20 million, validating the scalable nature of the

Read Full Article
bionity.combionity.com

eXoZymes Receives $2 Million From the NIH to Further Develop Cannabinoid Analogs for Drug Research.

eXoZymes Inc. – a pioneer in AI-powered enzymes enabling scalable manufacturing of nutraceuticals and novel drugs – announced that it has been recognized by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) for a grant...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Weatherford Democrat broke the news on Wednesday, June 24, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal